Dr. Ricardo Gonzalez

Dr. Ricardo Gonzalez
Dr. Gonzalez is a graduate of Stanford University School of Medicine and completed his residency and fellowship at Cornell in New York City. He currently practices urology with a focus on voiding dysfunction and pelvic restorative medicine reconstructive surgery at Houston Methodist Hospital in Houston, TX. He is a diplomate of the American Board of Urology (ABU) and has earned board subspecialty certification in female pelvic medicine and reconstructive surgery (FPMRS) through the ABU and ACOG. He is the Program Director for the fellowship in Pelvic Medicine and Reconstructive Surgery (FMPRS Urology) at Houston Methodist Hospital. He is an Associate Professor of Clinical Urology for Weill Cornell, Associate Professor of Urology for Texas A&M, the Houston Methodist Academic Institute and clinical faculty for Baylor College of Medicine. He is former Medical Director for the Centers for Voiding Dysfunction and Clinical Research at Houston Metro Urology. Dr. Gonzalez is an internationally-recognized expert in surgical therapies for BPH, including Aquablation and other therapies. He has been invited to teach BPH operations throughout the U.S. and in 19 foreign countries. His research interests include the development and evaluation of minimally invasive treatments that improve voiding function and urinary control in patients. His philosophy is that prostate treatments do not have to sacrifice sexual well-being. His goal is to provide state-of-the-art urologic care to improve patients’ quality of life.

Locations

Houston Methodist Urology Associates Houston, TX

6560 Fannin Street, Suite 2100Houston, Texas, 77030United States
713-441-6455 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only